Cleared Traditional

K061350 - LITHODIAMOND ULTRA

K061350 is an FDA 510(k) clearance for LITHODIAMOND ULTRA, manufactured by Pck Electronic Industry & Trade Co., Ltd.. The device is a Class 2 Gastroenterology & Urology device with product code LNS cleared through the Traditional 510(k) pathway after a 221-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2006
Decision
221d
Days
Class 2
Risk

K061350 is an FDA 510(k) clearance for the LITHODIAMOND ULTRA. Classified as Lithotriptor, Extracorporeal Shock-wave, Urological (product code LNS), Class II - Special Controls.

Submitted by Pck Electronic Industry & Trade Co., Ltd. (Washington, US). The FDA issued a Cleared decision on December 22, 2006 after a review of 221 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5990 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Pck Electronic Industry & Trade Co., Ltd. devices

FDA 510(k) Submission Details - K061350

510(k) Number K061350 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 15, 2006
Decision Date December 22, 2006
Days to Decision 221 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d slower than avg
Panel avg: 131d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LNS Device Classification - Class 2, Special Controls

Product Code LNS Lithotriptor, Extracorporeal Shock-wave, Urological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5990
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - LNS Lithotriptor, Extracorporeal Shock-wave, Urological

All 41
Devices cleared under the same product code (LNS) and FDA review panel - the closest regulatory comparables to K061350.
MODULARIS VARIOSTAR
K070799 · Siemens Medical Solutions USA, Inc. · Nov 2007
STORZ SLX-F2 STORM TOUCH
K070579 · KARL STORZ Endoscopy-America, Inc. · Aug 2007
ECONOLITH EM1000
K063504 · Medispec, Ltd. · Mar 2007
LITHOGOLD
K062081 · Tissue Regeneration Technologies, Inc. · Nov 2006
INTEGRA SL
K062147 · Direx Systems Corp. · Oct 2006
INTEGRA
K053640 · Direx Systems Corp. · Mar 2006